GC
INDV icon

Globeflex Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Globeflex Capital’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Hold
30,280
– – 0.16% 153
2026
Q1 		$923K Hold
30,280
– – 0.14% 165
2025
Q4 		$1.09M Buy
30,280
+23,164
+326% +$707K 0.17% 148
2025
Q3 		$172K Buy
+7,116
New +$149K 0.03% 315

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Globeflex Capital's INDV Position: Q2 2026 in Review

Globeflex Capital held its Indivior Pharmaceuticals (INDV) position steady in Q2 2026 at 30,280 shares worth $1.24M. The position accounts for 0.16% of the portfolio, ranked #153.

Globeflex Capital first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Globeflex Capital held 30,280 shares of Indivior Pharmaceuticals worth $1.24M as of Q2 2026.
  • Globeflex Capital left its Indivior Pharmaceuticals share count unchanged in Q2 2026.
  • Indivior Pharmaceuticals made up 0.16% of Globeflex Capital's portfolio in Q2 2026, its #153 holding.
  • Globeflex Capital first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.